-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Neutral on Biogen, Maintains $121 Price Target

Benzinga·06/12/2025 14:13:56
Listen to the news
Wedbush analyst Laura Chico reiterates Biogen (NASDAQ:BIIB) with a Neutral and maintains $121 price target.